XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 98,193 $ 114,846
Investment securities, available-for-sale 247,727 301,977
Accounts receivable, net 92,802 62,195
Interest and other receivables 1,730 885
Inventory 20,768 6,636
Prepaid expenses 37,950 21,398
Total current assets 499,170 507,937
Property and equipment, net 4,884 6,021
Operating lease right-of-use assets 50,758 55,573
Intangible assets, net 66,855 0
Restricted cash 5,770 5,770
Long-term inventory 4,628 4,924
Other assets 475 7,587
Total assets 632,540 587,812
Liabilities and stockholders’ equity    
Accounts payable 12,310 12,746
Accrued liabilities 197,293 112,884
Total current liabilities 209,603 125,630
Operating lease liabilities 48,103 52,695
Other long-term liabilities 12,660 9,074
Total liabilities 270,366 187,399
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at September 30, 2023 and December 31, 2022; no shares issued and outstanding at September 30, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at September 30, 2023 and December 31, 2022; 163,968,949 shares and 162,064,872 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 16 16
Additional paid-in capital 2,839,111 2,770,923
Accumulated deficit (2,476,634) (2,369,551)
Accumulated other comprehensive loss (319) (975)
Total stockholders’ equity 362,174 400,413
Total liabilities and stockholders’ equity $ 632,540 $ 587,812